In-vitro &in-vivo evaluation of novel l-carnosine loaded pegylated liquid crystalline nanoparticles
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-FDP-005
- By: GAAFAR, Passent (Department of Pharmaceutical Sciences, College of Pharmacy, Arab Academy for Science, Technology and Maritime transport. Alexandria, Egypt)
- Co-author(s): Passent M. E. Gaafar Department of Pharmaceutical Sciences, College of Pharmacy, Arab Academy for Science, Technology and Maritime transport. Alexandria, Egypt.
Ragwa M. Farid: Department of Pharmaceutical Sciences and Pharmaceutical Technology, Faculty of Pharmacy and Drug Manufacturing, Pharos university, Alexandria, Alexandria, Egypt
Heba A. Hazzah: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy and Drug Manufacturing, Pharos university, Alexandria, Alexandria, Egypt
Ossama Y. Abdallah: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
Maged W. Helmy: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt - Abstract:
Background
L-carnosine(CN) is a unique naturally occurring dipeptide anticancer drug. Several reports supported its strong anticancer activity as solution.
Methods
Novel PEGylated liquid crystalline nanoparticles incorporating CN were formulated by emulsification method. Different formulation variables including; poloxamer-407, glyceryl
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023